Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra A Springer

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
JAMA Network Open|May 30, 2025
Initiating Injectable Buprenorphine in People Hospitalized With Infections: A Randomized Clinical TrialNikhil Seval, Prerana Roth, Cynthia A Frank, et al.
Health & Justice|December 18, 2022
The impact of COVID-19 on the treatment of opioid use disorder in carceral facilities: a cross-sectional studyElizabeth C Saunders, Milan F Satcher, Laura B Monico, et al.
Plos One|May 23, 2018
Risk behaviors and HIV care continuum outcomes among criminal justice-involved HIV-infected transgender women and cisgender men: Data from the Seek, Test, Treat, and Retain Harmonization InitiativeCurt G Beckwith, Irene Kuo, Rob J Fredericksen, et al.
JAMA|December 1, 2022
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA PanelRajesh T Gandhi, Roger Bedimo, Jennifer F Hoy, et al.
Drug and Alcohol Dependence|November 10, 2018
Approaches for creating comparable measures of alcohol use symptoms: Harmonization with eight studies of criminal justice populationsAndrea M Hussong, Nisha C Gottfredson, Dan J Bauer, et al.
Journal of Substance Abuse Treatment|April 18, 2021
Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS)Elizabeth Needham Waddell, Sandra A Springer, Lisa A Marsch, et al.
JAMA|December 1, 2024
Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA PanelRajesh T Gandhi, Raphael J Landovitz, Paul E Sax, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2026
Multi-Center Real-World Implementation Outcomes of Lenacapavir for HIV Pre-Exposure ProphylaxisAniruddha Hazra, Philip A Chan, Meredith Clement, et al.
Substance Abuse Treatment, Prevention, and Policy|May 18, 2017
Cohort profile: seek, test, treat and retain United States criminal justice cohortRedonna Chandler, Michael S Gordon, Bridget Kruszka, et al.
AIDS (London, England)|October 13, 2020
Hazardous alcohol use, antiretroviral therapy receipt, and viral suppression in people living with HIV who inject drugs in the United States, India, Russia, and VietnamJennifer A Wagman, Adriane Wynn, Mika Matsuzaki, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
JAMA Network Open|May 30, 2025
Initiating Injectable Buprenorphine in People Hospitalized With Infections: A Randomized Clinical TrialNikhil Seval, Prerana Roth, Cynthia A Frank, et al.
Health & Justice|December 18, 2022
The impact of COVID-19 on the treatment of opioid use disorder in carceral facilities: a cross-sectional studyElizabeth C Saunders, Milan F Satcher, Laura B Monico, et al.
Plos One|May 23, 2018
Risk behaviors and HIV care continuum outcomes among criminal justice-involved HIV-infected transgender women and cisgender men: Data from the Seek, Test, Treat, and Retain Harmonization InitiativeCurt G Beckwith, Irene Kuo, Rob J Fredericksen, et al.
JAMA|December 1, 2022
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA PanelRajesh T Gandhi, Roger Bedimo, Jennifer F Hoy, et al.
Drug and Alcohol Dependence|November 10, 2018
Approaches for creating comparable measures of alcohol use symptoms: Harmonization with eight studies of criminal justice populationsAndrea M Hussong, Nisha C Gottfredson, Dan J Bauer, et al.
Journal of Substance Abuse Treatment|April 18, 2021
Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS)Elizabeth Needham Waddell, Sandra A Springer, Lisa A Marsch, et al.
JAMA|December 1, 2024
Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA PanelRajesh T Gandhi, Raphael J Landovitz, Paul E Sax, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2026
Multi-Center Real-World Implementation Outcomes of Lenacapavir for HIV Pre-Exposure ProphylaxisAniruddha Hazra, Philip A Chan, Meredith Clement, et al.
Substance Abuse Treatment, Prevention, and Policy|May 18, 2017
Cohort profile: seek, test, treat and retain United States criminal justice cohortRedonna Chandler, Michael S Gordon, Bridget Kruszka, et al.
AIDS (London, England)|October 13, 2020
Hazardous alcohol use, antiretroviral therapy receipt, and viral suppression in people living with HIV who inject drugs in the United States, India, Russia, and VietnamJennifer A Wagman, Adriane Wynn, Mika Matsuzaki, et al.
Pageof 13